Activation of many multidomain signaling proteins requires rearrangement of autoinhibitory interdomain interactions that occlude activator binding sites. In one model for activation, the major inactive conformation exists in equilibrium with activated-like conformations that can be stabilized by ligand binding or post-translational modifications. We established the molecular basis for this model for the archetypal signaling adaptor protein Crk-II by measuring the thermodynamics and kinetics of the equilibrium between autoinhibited and activated-like states. We used fluorescence and NMR spectroscopies together with segmental isotopic labeling by means of expressed protein ligation. The results demonstrate that intramolecular domain-domain interactions both stabilize the autoinhibited state and induce the activated-like conformation. A combination of favorable interdomain interactions and unfavorable intradomain structural changes fine-tunes the population of the activated-like conformation and allows facile response to activators. This mechanism suggests a general strategy for optimization of autoinhibitory interactions of multidomain proteins.
a r t i c l e s Many autoinhibited signaling proteins are responsive to small changes in the populations of cognate binding partners [1] [2] [3] [4] [5] . The dynamic equilibrium between autoinhibited and activated-like conformations of signaling proteins in the absence of activators is believed to play a key role in achieving the seemingly contradictory tasks of preventing uncontrolled activation and enabling prompt response to cellular stimuli 6, 7 . This model implies that the interdomain interface responsible for autoinhibition must be sufficiently stable to prevent constitutive activation, but sufficiently labile to allow facile kinetic exchange between autoinhibited and activation-competent states.
The conformation of a protein in complex with a target molecule must, in the absence of the target, have a free energy equal to or greater than that of the experimentally observed apo structure. Consequently, the binding affinity for the target must be sufficient to overcome the energetic penalty associated with forming higher-energy holo conformations 8 . Knowing the thermodynamics and kinetics of such conformational changes is critical for understanding the physical principles controlling binding affinity; however, detection of low populations of high-energy states in the absence of binding partners represents a considerable experimental challenge.
A full description of the molecular mechanisms responsible for controlling the dynamic equilibrium between autoinhibited (closed) and activated-like (open) states requires comparing the structures and thermodynamics of individual domains, in isolation and in the context of full-length molecules, as well as knowledge of the kinetics of interconversion between the various populated conformational states. Moreover, unique spectroscopic probes are needed for studying the individual domains within the full-length multidomain protein 9, 10 .
Consequently, complete descriptions of the molecular basis for control of autoinhibition of multidomain signaling proteins are not yet available.
Archetypical signaling adaptor proteins of the Crk family are comprised of Src homology 2 (SH2) and 3 (SH3) domains and have been implicated in many cellular processes including cell motility, proliferation and adhesion [11] [12] [13] [14] (Fig. 1a) . Through their SH2 and SH3 domains, Crk proteins mediate diverse protein-protein interactions in downstream transduction of growth and differentiation signals 11 . Crk-II consists of an N-terminal SH2 domain and two SH3 domains (SH2-nSH3-cSH3). The binding of the N-terminal SH3 (nSH3) domain to C3G (a guanine-nucleotide exchange factor for small-molecular-weight GTPase 15 ), Abl 16 and DOCK180 (ref. 17) contributes to integrin signaling 18 and the regulation of fibroblast migration 11 . The biological activity of the nSH3 domain of Crk-II is negatively regulated by the C-terminal SH3 (cSH3) domain through intramolecular domain-domain interactions 11, 19 . The solution structure of Crk-II shows that the cSH3 domain stabilizes a closed autoinhibited state of Crk-II in which the ligand-binding site of the nSH3 domain is blocked by interdomain interactions with the SH2 domain; however, the active site of the nSH3 domain is not directly occluded by the cSH3 domain 19 (Fig. 1b) . Alternative splicing of the cellular crk gene yields Crk-I (SH2-nSH3), which lacks the C-terminal SH3 domain and is constitutively active, causing transformation of hematopoietic and fibroblast cells 12, 20 . The NMR solution structure of Crk-I indicates that the active site of the nSH3 domain is exposed to solvent 19 , consistent with the inability of the SH2 domain to solely exert autoinhibitory control of nSH3 activity 9 . Various models have been a r t i c l e s proposed for control of autoinhibition of Crk-II (refs. 19, 21, 22) ; however, a complete biophysical analysis of this process, which necessarily involves analysis of the full-length protein and individual domains, has not been reported. Herein, we present a thermodynamic, kinetic and structural analysis that reveals a critical role for selective domain destabilization in tuning the responsiveness of Crk-II to activation.
RESULTS

Thermodynamics and kinetics of a dynamic equilibrium of Crk-II
Crk-II exists as an equilibrium mixture of the autoinhibited state and the open state, in which the binding site of the nSH3 domain is exposed to solvent ( Fig. 1c) . Target proteins can bind to the nSH3 domain of Crk-II only when the protein adopts an open state. We determined the free energy of the closed autoinhibited state relative to the open activated-like state of Crk-II from the binding affinity of a C3G-derived 23 ligand to the nSH3 domain in Crk-II and Crk-I. We estimated the binding affinity (K int ) of the ligand to the nSH3 domain in the open state using Crk-I (Online Methods). The free energy difference, ∆G° = G°o pen -G°c losed = 1.5 ± 0.1 kcal mol −1 , corresponds to closed and open state populations of p closed = 92.6% and p open = 7.4%, respectively, for Crk-II ( Table 1 and Supplementary Fig. 1) .
We estimated the kinetics of ligand binding to the nSH3 domain in the context of full-length Crk-II from an NMR-detected titration experiment using uniformly 15 N-labeled Crk-II and fluorescein-labeled C3G-derived ligand. Two 15 N resonances in the nSH3 domain, W169 (∆ω N = ω bound -ω free = 790 s −1 ) and A172 (∆ω N = 165 s −1 ), underwent slow and fast chemical exchange, respectively, relative to the NMR chemical shift timescale, upon addition of ligand ( Fig. 1d) . Therefore, the chemical exchange rate constant is 165 s −1 < k ex < 790 s −1 , corresponding to a bimolecular on-rate constant of 5.8 × 10 9 M −1 s −1 < k on < 2.8 × 10 10 M −1 s −1 for ligand binding to the nSH3 domain in the open state of Crk-II. The observed K d is 1.9 orders of magnitude lower for fluorescein-labeled C3G ligand than for the unlabeled ligand 24 . Assuming that k off is unaffected by the presence of the label, we estimated 6.5 × 10 7 M −1 s −1 < k on < 3.1 × 10 8 M −1 s −1 for an unlabeled ligand (Online Methods). These results are in excellent agreement with measured on-rates for ligand binding to isolated SH3 domains 25 and thus support use of Crk-I to estimate the intrinsic ligand-binding affinity, K int , for the open state of full-length Crk-II ( Fig.1c and Table 1 ).
Collectively, these results demonstrate that regulation of the interconversion between the open and closed autoinhibited conformations plays a central role in controlling Crk-II function. These data also show that the stability of the interface with the cSH3 domain limits the activation rate of Crk-II, because autoinhibition must be relieved in order for the open state to populate.
Intra-and interdomain interactions in the closed state
A considerable basal population (~7%) of the open states of Crk-II persists, even though a large solvent-accessible surface area (~1,360 Å 2 ) is buried between the cSH3 and other domains in the structure of autoinhibited Crk-II ( Fig. 1a) . We quantified the energetics of the interdomain interactions by comparing the stability of the cSH3 domain in isolation and in full-length Crk-II. The unfolded cSH3 domain cannot bind to the other domains of Crk-II; consequently, unfolding and dissociation of the cSH3 domain are thermodynamically linked. The effect of ligand binding on global unfolding, measured by monitoring the change in T m or hydrogen/deuterium (H/D) exchange, has been reported for other isolated SH3 domains 26, 27 .
NMR-detected backbone amide H/D-exchange experiments are routinely used to measure the unfolding free energy of small-to intermediate-sized proteins (<25 kDa); however, peak overlap makes the application of the H/D-exchange experiment difficult for large (>30 kDa) proteins. We used expressed-protein ligation (EPL) 28 to produce segmentally labeled full-length Crk-II, in which only the cSH3 domain is labeled with 15 N (SH2 14N -nSH3 14N -cSH3 15N ) ( Fig. 2a) .
Owing to the simplified NMR spectrum, all of the expected 1 H-15 N resonances in the cSH3 domain were detected in segmentally labeled full-length Crk-II (~34 kDa) ( Fig. 2b and Supplementary Fig. 2) .
We measured H/D-exchange rates at 290 K for 20 residues (Fig. 2c ) located in and around the hydrophobic core of the cSH3 domain ( Fig. 2d) . Unexpectedly, the protection factors are nearly equal or larger in the isolated cSH3 domain (average ∆G ex = 5.58 ± 0.52 kcal mol −1 ) relative to the values measured for the cSH3 domain within full-length Crk-II (average ∆G ex = 5.29 ± 0.41 kcal mol −1 ) ( Fig. 2c) . 1 H and 15 N chemical shifts ( Fig. 3a,b ) and 15 N transverse relaxation rate a r t i c l e s measurements ( Fig. 3c ) demonstrate that the similarity in the protection factors of the cSH3 domain in isolation and in the full-length Crk-II are not due to dissociation of the cSH3 domain from the other domains in Crk-II. These results indicate that the cSH3 domain does not experience any net favorable interdomain binding free energy, even though a large surface area is buried in the autoinhibited state. We characterized the conformational properties of the linker region between the nSH3 and cSH3 domains, residues 224-237, in full-length Crk-II. Heteronuclear { 1 H}- 15 N NOE values in full-length Crk-II are <0.6 for residues in the linker, compared with values >0.6 for residues in elements of secondary structure, and are similar to values measured for the isolated cSH3 domain (Fig. 3d) . We did not observe any resonance cross-peaks in the first NMR spectrum in H/D-exchange experiments for residues in the linker region in full-length Crk-II, indicating that amide proton-exchange protection factors are small. We note that segmentally labeled protein must be used to measure accurate NMR H/D-exchange and spin-relaxation parameters for the linker region, owing to the substantial spectral overlap in uniformly labeled Crk-II, which prevents quantitative peak-intensity measurements ( Supplementary Fig. 3 ). Thermodynamically unfavorable interactions thus must occur simultaneously in the cSH3 domain, and not the linker, upon formation of the thermodynamically favorable domain-domain interface of the autoinhibited state.
Conformational change of Trp275 within the cSH3 domain
We investigated the structural changes in the cSH3 domain that may offset favorable interdomain interaction and thereby allow facile activation of Crk-II. The backbone 15 N and 1 H chemical shifts of the cSH3 domain in the context of autoinhibited Crk-II and activated Crk-II (Crk-II bound to C3G-ligand, Crk-II/C3G) are broadly similar (Fig. 3b) , indicating that modest conformational changes around the interdomain interface of the cSH3 domain are sufficient to induce the Fig. 3b and Supplementary Fig. 2) . Trp275 is highly conserved in Crk-II (Supplementary Fig. 4 ) and is critical for stabilizing the cSH3 domain and the autoinhibited state of Crk-II 19, 29 . H/D-exchange experiments show that the side chain indole 1 H ε1 of Trp275 is well protected from solvent in the isolated cSH3 domain ( Supplementary  Fig. 5a,c) , but not in full-length Crk-II ( Supplementary Fig. 5b,d) .
We conducted fluorescence experiments to confirm that Trp275 is protected from solvent exposure in the isolated cSH3 domain 30, 31 . The tryptophan fluorescence-emission maximum is blue-shifted compared with free indole ( Table 2) . We also compared the Stern-Volmer constant (K sv ) of the isolated cSH3-WT domain to free indole ( Table 2) .
The fluorescence results show that Trp275 has a single conformation in which the side chain is buried into the hydrophobic core. These results imply that domain-domain interactions in full-length Crk-II perturb the hydrophobic core of the cSH3 domain by switching Trp275 to a more exposed conformation. The solvent protection of the side chain of Trp275 is consistent with the solution structure of the isolated cSH3 domain (PDB 2GGR). The indole ring of Trp275 is packed against several hydrophobic residues, resulting in the burial of 1,117 Å 2 of hydrophobic surface area 32 . In contrast, Trp275 populates a different χ 1 and χ 2 rotamer in full-length Crk-II, and the indole ring is flipped toward the binding interface with the SH2 domain ( Fig. 4a) .
Rotameric mutation of Trp275 using noncoded amino acid
We sought to design a mutant of cSH3 that would mimic the conformation of Trp275 observed in full-length Crk-II. The energetic consequences of local conformational changes of a single tryptophan residue are difficult to evaluate using traditional mutagenesis, because substitutions conserving size and molecular structure cannot be made using natural amino acids. We selectively replaced Trp275 in the isolated cSH3 domain by the non-natural amino acid 7-aza Trp (7AW), in which the carbon atom in the 7-position of the indole ring is replaced by nitrogen. This mutation does not perturb the structure of the side chain, except for the increased polarity of the ring. The 7-position of the Trp275 side chain is buried in the hydrophobic core of the isolated cSH3, and we reasoned that the side chain of 7AW would reorient to expose the 7-position to solvent, mimicking the effects of changing the χ 1 rotamer of Trp275 in Crk-II (Fig. 4a) . The 7AW substitution can thus be used as a 'rotameric mutation' . The effect of 7AW on the stability of the cSH3 domain was measured using urea-induced denaturation. The stability of the isolated cSH3-7AW domain was decreased by almost ~1 kcal mol −1 relative to wild-type isolated cSH3 ( Table 2 and Supplementary Fig. 6) . The m-value also decreased, indicating that the hydrophobic core is slightly perturbed in cSH3 7AW , compared to wild-type cSH3.
We conducted fluorescence quenching experiments to confirm that the 7AW substitution perturbed the rotameric conformational state of Trp275 (refs. 30, 31) . We compared the K sv of the isolated cSH3-7AW domain to that of free 7-azaindole, because of the difference in intrinsic quenching efficiencies of tryptophan and 7AW ( Table 2 and Fig. 4b,c) . The result for the cSH3-7AW domain shows that the protein populates major (~89%) and minor (~11%) conformations corresponding to the buried and exposed conformation of the side chain of 7AW, respectively. In addition, the 1 H-15 N HSQC spectrum of the cSH3-7AW showed that several resonances from residues near 7ATrp275 are split into two peaks, further confirming the presence of two different conformations (data not shown). In contrast, the spectrum of the isolated wild-type cSH3 domain showed single resonance peaks for each residue. These results demonstrate that the incorporation of 7AW induces the rotation of the side chain toward the surface of the cSH3 domain (Fig. 4a) . We used these data in combination with the unfolding free energy of the cSH3-7AW ensemble to estimate an energetic penalty of 2.04 ± 0.38 kcal mol −1 for rotation of Trp275 in the autoinhibited form of Crk-II (for details see Supplementary  Methods) . The substantial energetic penalty incurred when the side chain of Trp275 flips out to enable favorable interdomain interactions provides an explanation for the absence of stabilization of the cSH3 domain in the context of full-length Crk-II.
DISCUSSION
Quantifying the energetics of the structural changes on domaindomain interactions is central to understanding signaling processes at the molecular level. We have developed a self-consistent a d a r t i c l e s thermodynamic and kinetic model for the control of the autoinhibition of Crk-II, in which favorable domain-domain interactions are balanced by structural changes, including perturbations of Trp275, that reduce the stability of the cSH3 domain, in order to avoid overstabilization of the autoinhibited state (Fig. 4d) . The moderate conformational change of the side chain of Trp275 destabilizes the cSH3 domain by a surprisingly large ~2 kcal mol −1 . However, packing interactions in the hydrophobic core of SH3 domains are highly conserved, and domain stability is very sensitive to perturbations of the hydrophobic core 33 . The hypothetical binding energy between the cSH3 and SH2 domains of Crk-II that would be expected if exposure of the Trp275 side chain were not energetically unfavorable is an important quantity to use in assessing whether additional conformational changes contribute to the free-energy difference between the closed and open states. The intramolecular binding energy between the two domains can be estimated using the relationship K a,intra = K a,inter × C effective , where C effective is the effective local concentration of the binding domain, and K a,inter is the intermolecular binding affinity 34 . The intermolecular binding constant between the cSH3 and SH2 domains of Crk-II is not known; however, the Abl SH3 domain binds to a proline-rich peptide sequence derived from the DE-loop of the Crk-II SH2 domain with K a,inter ~360 µM (ref. 35) . A theoretical investigation of the intramolecular interaction of SH3 domains showed that the effective local concentration is ~80 mM when two domains are separated by the optimum linker length 34 . The hypothetical intramolecular binding energy, in which the unfavorable interaction of Trp275 is not considered, would thus be approximately −3.2 kcal mol −1 . This result is consistent with our estimation of the freeenergy difference between the closed state and open states in which the Trp275 side chain is buried (Fig. 4d) . The offset of the favorable interdomain interaction (about −3.2 kcal mol −1 ) by unfavorable conformational change from buried to exposed conformations of Trp275 (~2 kcal mol −1 ) reduces the free-energy difference between the closed and open states to ~1.2 kcal mol −1 . The self-consistency between this latter quantity and the difference measured independently ( Table 1) indicates that the conformational change associated with Trp275 is the dominant contribution to tuning the free-energy difference between autoinhibited and activated-like states of Crk-II. The free energy of the intramolecular binding of the cSH3 domain to other regions of Crk-II is relatively small, compared to other SH3-ligand interactions, perhaps because the intramolecular-binding interface of Crk-II is not optimized for ideal binding 36 .
Two other models have been proposed for control of autoinhibition of Crk-II. In the first model, autoinhibition of chicken Crk-II is controlled by interactions between the nSH3 and cSH3 domain, mediated by means of isomerization of Pro237 (ref. 37 ). However, that work made use of a truncated Crk construct (nSH3-cSH3) that lacked the SH2 domain. The nSH3 and cSH3 domains do not directly interact in the structure of the full-length human protein 19 . In addition, the amino acid sequence adjacent to Pro237 in the chicken Crk-II sequence differs from the corresponding human and mouse sequences (Supplementary Fig. 4) . These differences suggest that the regulatory mechanism of chicken Crk-II may be different from that of human and mouse Crk-II. In the second model, the autoinhibited state of human Crk-II is stabilized by rigidification of the linker region (residues 224-236) tethering the nSH3 and cSH3 domains 19 . However, heteronuclear NOE data (Fig. 3d) indicate that the linker region experiences extensive conformational fluctuations on picosecond to nanosecond time scales. In addition, the H/D-exchange data indicate that the linker region undergoes slower interconversion between associated (exchange noncompetent) and dissociated (exchange competent) states with minor free energy differences.
In conclusion, intramolecular domain-domain interactions induce differential effects on the thermodynamic stabilities of individual domains to finely adjust the overall functional response of Crk-II. The interplay of these competing effects acts as the driving force to induce the basal level of the open (activated-like) state required for activation of Crk-II. The thermodynamically unfavorable conformational change of the cSH3 domain upon autoinhibition contributes to timely activation in response to cellular stimuli. The mode of regulation revealed by the present study is likely to be found in other multidomain proteins. In the limiting case, order-to-disorder transitions may maximally offset favorable domain-domain interactions 38 .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
ONLINE METHODS
Protein expression and purification. Detailed procedures for preparation of samples of mouse Crk-II are described in Supplementary Methods. Intactness of segmentally labeled Crk-II was confirmed by comparing the NMR chemical shifts and R 2 relaxation rate constants with those of uniformly 15 N labeled Crk-II that was prepared by means of a conventional method (Supplementary Fig. 7) . Isolated cSH3 domain was confirmed to be monomeric by measuring the concentration-dependent NMR transverse relaxation rate constants (Supplementary Fig. 7) .
Ligand-binding assays. A fluorescence-based titration assay was used to measure the affinity constants of both C3G ligand 15 and a phosphopeptide ligand 39 . All ligandbinding measurements were conducted at 25 °C in a stirred 1-cm-pathlength cuvette. The excitation wavelength was 295 nm. C3G ligand, HPPPPLPPKRRK-εfluorescein-G-NH 2 , was prepared by solid-phase peptide synthesis. Dissociation constants were calculated by assuming the formation of a 1:1 complex and by fitting corrected fluorescence intensities to the equation:
where F and ∆F are the change and maximum change in protein fluorescence, respectively, P is the total protein concentration, L is the total ligand concentration, and K d is the equilibrium dissociation constant. Experiments were done in triplicate. The free-energy difference between the open and closed states of Crk-II was calculated using equation (2) . In our three-state binding model (Fig. 1c) , the equilibrium constant (K O ) for the opening and closing process between the closed (C) and open (O) states of Crk-II was calculated from the apparent binding affinity (K d ) and the binding affinity (K int ) of the C3G ligand: where k on and k off represent bimolecular on-rate and unimolecular off-rate constants, respectively, between the open and ligand-bound states (Fig. 1c) , [L] represents the free ligand concentration, and K int represents the dissociation constant of C3G ligand to Crk-I. The reported k on was calculated with K O of 0.074 (p open = 7.4% in Crk-II) and [L] free = 0.077 µM (protein:ligand = 1:0.22). The NMR titration experiment (Fig. 3c) showed that the exchange rate is 165s −1 < k ex < 790 s −1 at this protein:ligand ratio resulting in 5.8 × 10 9 M −1 s −1 < k on < 2.8 × 10 10 M −1 s −1 . The observed K d for fluorescein-labeled C3G ligand is 1.1% of that for fluorescein-free C3G-ligand 24 . Despite this effect of fluorescein, the label is necessary to quantify the concentration of ligand in solution, because the ligand sequence lacks suitable spectroscopic probes and measurements of peptide concentrations using amino acid analysis have large errors. Therefore, the observed k on rate was corrected by the ratio of K d for label-free and fluorescein-labeled ligand. The correction yields estimates of 6.5 × 10 7 M −1 s −1 < k on < 3.1 × 10 8 M −1 s −1 .
NMR spectroscopy. A Bruker DRX600 NMR spectrometer equipped with a CryoProbe was used. Chemical shifts for different protein states and complexes (1)
(2)
(3)
(4) (4)
were measured in a buffer containing 10 mM sodium phosphate (pH 7.0), 100 mM NaCl, 2 mM DTT, at 298 K. Chemical-shift changes were calculated as:
